00:00:00Introduction
00:01:33First-Line Treatment
00:20:36Bispecific Antibodies and Chimeric Antigen Receptor T-Cell Therapy
이 에피소드에 관해
영어
미국
노트보기 🔗
전사 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
이 팟캐스트의 다른 에피소드
Featuring an interview with Dr Alexander E Drilon, including the following topics:
Overview of targetable biomarkers in lung cancer (0:00)
Biomarker testing for genomic alterations in lung cancer (5:24)
Overview of ROS1 alterations in lung cancer (13:44)
Efficacy data with ROS1 inhibitors for lung…
Featuring perspectives from Dr Samuel J Klempner and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics:
Introduction (0:00)
First-Line Treatment of Metastatic Gastroesophageal Cancer (1:48)
Management of HER2-Positive Gastroesophageal Cancer (25:11)
Neoadjuvant Thera…
Featuring perspectives from Dr Joyce F Liu, Dr David M O'Malley and Dr Brian M Slomovitz, moderated by Dr O'Malley, including the following topics:
Case: A woman in her mid 60s with metastatic serous endometrial carcinoma that is HER2 IHC 3+ who received first-line carboplatin/paclitaxel/trastuzum…
Featuring perspectives from Dr Shannon N Westin and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics:
Introduction (0:00)
Ovarian Cancer (2:22)
Endometrial Cancer (37:48)
CME information and select publications
Featuring an interview with Professor Nicoletta Colombo, including the following topics:
Mechanistic effects and rationale underlying the use of relacorilant/nab paclitaxel (0:00)
Rationale underlying the study design of the Phase II BELLA trial and avenues for future exploration (8:31)
Definition…
면책 조항: 이 페이지에 포함된 팟캐스트와 작품은 Dr. Neil Love에서 가져온 것입니다. 이 팟캐스트는 소유자의 재산이며 Listen Notes, Inc.와 제휴하거나 보증하지 않습니다.
